NORD Holding sells Alsitan to the Management
Alsitanwww.alsitan.com) is a pharmaceutical company that sells over the counter herbal drugs and dietary supplements through health food stores, as a contractual producer for neuform and through drugstores.
After being acquired by Nord Holding and Mr. Specht sen. in 1998 in a buy-in from the previous family owners, the company has more than doubled turnover to € 14 mil. Alsitan is thus a prime example of a successfully implemented successor issue in a medium sized company, whereby with the support of NORD Holding the company has been able to strategically re-position itself, develop its operative business and transfer to a new business dynasty.
About NORD Holding
With its 50-year history and over € 2.0 billion Assets under Management, NORD Holding is one of the leading Private Equity Asset Managers in Germany with a focus on direct and fund investments.
The direct investments division of NORD Holding focuses on structuring and financing company succession models, acquiring parts of larger groups/subsidiaries as well as on expansion financing of medium-sized companies. In contrast to most other financial investors, who only manage closed-end funds, NORD Holding acts as a so-called "evergreen fund", thereby investing from its own balance sheet with no maturity restrictions. Currently, the fund has interests in more than 15 companies in the DACH region.
The fund investments division targets the small- and mid-cap segment of the European private equity market through primaries, secondaries and co-investments.
NORD Holding has a strong focus on emerging buyout managers, hands-on investment strategies and regularly acts as an anchor investor. The division manages € 1.3 billion and ranks among the top decile fund investment groups in Europe.